Pfizer Highlights Oncology Innovation and Advances in Next-Generation Pipeline at ASCO 2026 Pfizer Inc. (NYSE: PFE) has announced an extensive and data-rich presence at the American Society of Clinical Oncology Annual Meeting 2026, scheduled to take place from May 29…
AHF Initiates Statewide Campaign Calling for Full Reinstatement of Florida’s AIDS Drug Assistance Program The AIDS Healthcare Foundation (AHF) has launched a statewide public awareness campaign urging Ron DeSantis and the Florida Legislature to take immediate and permanent action to…
Real Time Medical Systems Highlights New Leadership, AI Solutions, and Expanded Partnership at NAACOS Spring 2026 Real Time Medical Systems (Real Time), a KLAS-rated and HITRUST R2 Certified leader in post-acute care analytics, announced today its participation in the National…
Wound Healing Society Acknowledges Eluciderm, Inc. with Industrial R&D Award for Advancing ELU42 Mechanism of Action Research Eluciderm, Inc., a clinical-stage biopharmaceutical organization focused on the development of innovative small-molecule therapies designed to enhance tissue repair and regeneration, has announced…
Entos Pharmaceuticals and L-CMD Research Foundation Join Forces to Develop Curative Therapy for LMNA-Related Congenital Muscular Dystrophy Entos Pharmaceuticals Inc has announced a strategic collaboration with the L-CMD Research Foundation aimed at accelerating the development of transformative therapies for LMNA-related…
Palleon Pharmaceuticals Showcases First-in-Class B7-H3–Targeted Sialidase at AACR 2026 Palleon Pharmaceuticals has unveiled new preclinical findings and announced the initiation of a first-in-human clinical trial for its novel oncology candidate E-688/HLX316 during the American Association for Cancer Research Annual Meeting.…
FDA Prioritizes Review of KEYTRUDA® and KEYTRUDA QLEX™ Combinations with Padcev® for Cisplatin-Eligible Muscle-Invasive Bladder Cancer Patients Merck & Co., known as MSD outside the United States and Canada, has announced a significant regulatory milestone as U.S. Food and Drug…
Lundbeck highlights AAN 2026 data showing real-world improvements in migraine-related cognitive symptoms with VYEPTI® (eptinezumab-jjmr) Lundbeck has presented new real-world data from its ongoing INFUSE study at the American Academy of Neurology Annual Meeting 2026, offering fresh insights into the…
Agenus highlights durable survival and immune reprogramming in PD-1 refractory gastroesophageal cancer with Botensilimab combo Agenus Inc., a company focused on advancing immuno-oncology innovation, has reported new clinical findings from an investigator-initiated Phase II study evaluating a multi-agent immunotherapy-based regimen…
HSS Study Evaluates Non-Opioid Pain Relief Following Orthopedic Surgery A retrospective study presented at the 51st Annual Regional Anesthesiology and Acute Pain Medicine Meeting by investigators at Hospital for Special Surgery (HSS), the world’s leading academic medical center focused on…
Byondis to Present Data from its Novel ADC Technology Platforms at the American Society for Cancer Research Meeting 2026 Byondis B.V., an independent biotechnology company focused on developing next-generation targeted therapies for cancer, is showcasing its latest scientific advances at…
Ferring Pharmaceuticals and Gallup Announce Landmark Global Public Attitudes Study on Fertility and Family-Building Ferring Pharmaceuticals and Gallup today announced the Ferring Global Fertility Monitor, a global study on the factors influencing people’s fertility choices, at the 2026 Annual Convening…